ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Nov 15, 2011
Valuentum's November Edition of its Best Ideas Newsletter
The November edition of our Best Ideas Newsletter is now available.
Nov 11, 2011
Disney's Fiscal Fourth-Quarter Strong; Income Expands Across All Five Segments
Disney posted solid fiscal fourth-quarter results that revealed segment income growth across the board. Revenue from its parks and resorts division was also strong, indicating the continued resilience of the consumer.
Nov 3, 2011
Kellogg's Cutbacks Coming Home to Roost; Posts Weak Third Quarter and Outlook
Kellogg reported weak third-quarter results and issued a weak outlook for 2012 citing the need to improve its supply chain after drastic cutbacks in recent years. We remain on the sidelines.
Nov 3, 2011
A Tale of Two Teen Retailers: Abercrombie & Fitch, Aeropostale
Abercrombie & Fitch and Aeropostale reported third-quarter sales. The resulting stock price performance from the two was completely opposite: Abercrombie fell sharply, while Aeropostale shot up significantly. We think Abercrombie is a bargain at these levels, though Aeropostale is fairly valued.
Nov 3, 2011
Kraft Shows Off Pricing Power in Third Quarter; Raises 2011 Outlook
Kraft posted excellent third-quarter results that showed 7 percentage points of pricing expansion. We were impressed with the firm's performance, and we are maintaining our above-market fair value estimate.
Nov 2, 2011
Excellent Third-Quarter Results from Eastman Chemical
Eastman Chemical put up solid third-quarter results. We continue to evaluate the firm for addition to our Best Ideas portfolio.
Nov 2, 2011
Clorox Posts Fiscal First-Quarter Results; Reaffirms 2012 Outlook
Clorox posted less-than-impressive fiscal first-quarter results, as higher commodity costs took their toll. Management expects gross margins will remain flat through fiscal 2012, but we disagree. We remain on the sidelines, despite the firm's solid cash-flow generation.
Nov 2, 2011
Pfizer Reports Decent Third-Quarter Results; Loss of Exclusivity on Blockbuster Drug Lipitor Concerning
All things considered, we're less than thrilled with Pfizer. The firm will be losing exclusivity on its $10-billion-per-year blockbuster drug Lipitor at the end of November, and its earnings-per-share expansion is largely driven by buybacks. Though its valuation is compelling, there are better opportunities out there.
Oct 31, 2011
Precision Castparts Reports Strong Fiscal Second Quarter; Aerospace Growth Remains Impressive
Metal-bender Precision Castparts reported solid fiscal second-quarter results. Boeing's 787 Dreamliner to be key driver going forward.
Oct 26, 2011
Under Armour Posts Strong Third Quarter; Shares Remain Overvalued
Under Armour posted strong third-quarter results, but we think the stock remains overvalued.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.